About Particle Sciences
Particle Sciences is a Healthcare company based in Bethlehem (United States) founded in 2001, and was acquired by Agno Pharma in December 2023. Drug-eluting devices are designed and formulated by Particle Sciences. Particle Sciences offers products and services including API Manufacturing, Drug Product Development, Analytical Services, and Sterile APIs. Its focus areas include Biopharma Outsourcing, CDMO and Diversified. Its legal entity is Agno Pharmaceuticals. Its competitors include Patheon, LakePharma and Maravai Life Sciences; 2 of its 3 listed competitors have raised funding.
Company details
Particle Sciences is a full-service CDMO that is offering formulation development services and a comprehensive suite of supporting services including analytic, bioanalytic, physical characterization and manufacturing. It specialises in drug-device combination (mainly drug eluting) products and claims to have the industrys only complete design to commercialization solution for hormone eluting devices (including a proprietary performulation approach). Around 50 of the companies development work has been with parenterals. They also cater to oral, topicalmucosal and ocular dosage forms. The company has capabilities for the development of small molecules (including High Potency and BCS Class I - IV drugs), and biologics. Particle Sciences other services include API formulation and development, micro and nanotechnology based drug delivery, clinical-scale GMP manufacturing, analytic and bioanalytic testing, physical characterization, drug release testing, toxicology and pharmacokinetic services. In September 2015, Lubrizol acquired Particle Sciences for an undisclosed sum.
- Headquarters Bethlehem, United States
- Stage Acquired
- SectorsHealthcare
- Website particlesciences.com
- Social LinkedIn Facebook
- Acquired by Lubrizol (Sep 2015)
- Legal Name Agno Pharmaceuticals
- InvestorsLubrizol
& 1 more
- Acquired by
Products & Services of Particle Sciences
Particle Sciences offers a comprehensive portfolio of products and services, including API Manufacturing, Drug Product Development, Analytical Services, and Sterile APIs.
Handles synthesis and cGMP production of active pharmaceutical ingredients
Offers complex formulation and manufacturing for injectables and implants
Provides method development and stability programs for drug validation
Produces sterile and high-potency APIs for pharmaceutical applications
Investors in Particle Sciences
Particle Sciences has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Lubrizol and Agno Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Specialty chemicals for additives, materials, and oil fields are manufactured. | 1928 | lubrizol.com | Wickliffe, United States | |
Offers pharmaceutical contract development and manufacturing services globally. | 2003 | agnopharma.com | Piscataway, United States |
Investor details for Particle Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Particle Sciences
3 dated milestones of Particle Sciences across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Particle Sciences is founded.
- Exit Acquired by Lubrizol.
- Exit Acquired by Agno Pharma.
Competitors of Particle Sciences
Particle Sciences has 3 listed competitors in our database, 2 of them funded. They include Patheon, LakePharma and Maravai Life Sciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| patheon.com | 1974 | Durham, United States | $141M | Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry | ||
| lakepharma.com | 2009 | Belmont, United States | $30M | 212 | Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering | |
| maravai.com | 2014 | San Diego, United States | 650 | Provides enabling tools and services in the life sciences research and bio-production industries |
Detailed competitors of Particle Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Particle Sciences
Websites that share an audience with Particle Sciences (particlesciences.com).
Websites whose visitors overlap most with Particle Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
engineering.leeds.ac.uk | engineering.leeds.ac.uk | 100% | – | ||
microscopy.ethz.ch | microscopy.ethz.ch | 73% | – | ||
| aptuit.com | 73% | View details | |||
en.wikipedia.org | en.wikipedia.org | 48% | – | ||
bbc.co.uk | bbc.co.uk | 46% | #80 | – |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Particle Sciences (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Particle Sciences
Complete news archive for Particle Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Particle Sciences
Particle Sciences was founded in 2001.
Particle Sciences is headquartered in Bethlehem, United States.
Particle Sciences is a full-service CDMO that is offering formulation development services and a comprehensive suite of supporting services including analytic, bioanalytic, physical characterization and manufacturing. It specialises in drug-device combination (mainly drug eluting) products and claims to have the industrys only complete design to commercialization solution for hormone eluting devices (including a proprietary performulation approach). Around 50 of the companies development work has been with parenterals. They also cater to oral, topicalmucosal and ocular dosage forms. The company has capabilities for the development of small molecules (including High Potency and BCS Class I - IV drugs), and biologics. Particle Sciences other services include API formulation and development, micro and nanotechnology based drug delivery, clinical-scale GMP manufacturing, analytic and bioanalytic testing, physical characterization, drug release testing, toxicology and pharmacokinetic services. In September 2015, Lubrizol acquired Particle Sciences for an undisclosed sum.
Particle Sciences's top competitors include Patheon, Maravai Life Sciences and LakePharma.
Particle Sciences offers API Manufacturing, Drug Product Development, Analytical Services, and Sterile APIs.
Particle Sciences has 2 investors. Key investors include Lubrizol, and Agno Pharma.
Particle Sciences operates through Agno Pharmaceuticals.
Yes. Particle Sciences was acquired by Lubrizol in September 2015.